Eli Lilly and Company
Anti-PACAP antibody

Last updated:

Abstract:

Antibodies to human pituitary adenylate cyclase-activating peptide, compositions comprising such antibodies, and methods of using such antibodies for the treatment of pain including headache and/or migraine.

Status:
Grant
Type:

Utility

Filling date:

22 Nov 2019

Issue date:

23 Mar 2021